Optimizing aerosolization of a high-dose L-arginine powder for pulmonary delivery
In this study a carrier-free dry powder inhalation (DPI) containing L-arginine (ARG) was developed. As such, it is proposed that ARG could be used for adjunctive treatment of cystic fibrosis and/or tuberculosis. Various processing methods were used to manufacture high-dose formulation batches consis...
Main Authors: | Satu Lakio, David A.V. Morton, Anna P. Ralph, Pete Lambert |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-12-01
|
Series: | Asian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1818087615000616 |
Similar Items
-
The Influence of Force Control Agents on the Cohesive-Adhesive Balance in Dry Powder Inhaler Formulations
by: Philippe Begat, et al.
Published: (2014-03-01) -
Successful Use of Easyhaler® Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical Trials
by: Annette Kainu, et al.
Published: (2024-01-01) -
The Use of a Three-Fluid Atomising Nozzle in the Production of Spray-Dried Theophylline/Salbutamol Sulphate Powders Intended for Pulmonary Delivery
by: Stefano Focaroli, et al.
Published: (2020-11-01) -
Inhalable Dry Powder of Bedaquiline for Pulmonary Tuberculosis: In Vitro Physicochemical Characterization, Antimicrobial Activity and Safety Studies
by: Mohammad A. M. Momin, et al.
Published: (2019-10-01) -
Aggregated Nanotransfersomal Dry Powder Inhalation
of Itraconazole for Pulmonary Drug Delivery
by: Mehdi Hassanpour Aghdam, et al.
Published: (2016-03-01)